Press release - No. 10 / 2017
Zealand Pharma will attend the Jefferies Healthcare Conference in London and the Bryan Garnier & Co Healthcare Conference in
Paris, both in November
Copenhagen, November 7, 2017 - Mats Blom, Executive Vice President and Chief Financial Officer of Zealand Pharma, will be
attending the Jefferies Healthcare Conference, London, on Wednesday, November 15, 2017. Britt Meelby Jensen, President and Chief
Executive Officer (CEO) of Zealand Pharma, will be attending the Bryan Garnier & Co Healthcare Conference, Paris, on Thursday,
November 16, 2017.
For further information, please contact:
Mats Blom, Executive Vice President and Chief Financial Officer
Tel.: +45 31 53 79 73, e-mail: mabl@zealandpharma.com
About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq Copenhagen and New York: ZEAL) ("Zealand") is a biotechnology company focused on the discovery, design
and development of innovative peptide-based medicines. Zealand has a portfolio of medicines and product candidates under license
collaborations with Sanofi and Boehringer Ingelheim as well as a pipeline of internal product candidates focusing on specialty
gastrointestinal and metabolic diseases.
Zealand is based in Copenhagen (Glostrup), Denmark. For further information about the Company's business and activities, please
visit www.zealandpharma.com or follow Zealand on LinkedIn or Twitter @ZealandPharma.
Attachments:
http://www.globenewswire.com/NewsRoom/AttachmentNg/540b77f9-fb59-41c5-b051-af72a6b06d33
